Cryselle Kit
Product Images NDC 0480-3493

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 0480-3493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Cryselle Image 1)

Chemical structure diagram of the active ingredient Ethinyl Estradiol showing rings, double bonds, and functional groups including hydroxyl and ethynyl groups.*

FDA Label Image

2 (Cryselle Image 2)

Chemical structure of Norgestrel and Ethinyl Estradiol, the active ingredients in Cryselle oral kit by Teva Pharmaceuticals.*

FDA Label Image

1 (Cryselle Image 3)

A forest plot chart showing effect estimates (OR, RR, HR) from various health studies comparing combined oral contraceptive (COC) use versus never use. The horizontal axis represents effect estimates from -1.50 to 2.00. Data points with confidence intervals from multiple cohort and family planning studies are plotted, illustrating associations in the context of COC use.*

FDA Label Image

1 (Cryselle Image 4)

An effectiveness chart illustrating contraceptive methods and associated pregnancy rates per 100 women per year. The chart ranks methods from fewer pregnancies—such as implants, injections, intrauterine devices, and sterilization—to more pregnancies with no birth control. Categories include birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

2 (Cryselle Image 5)

Cryselle 0.3 mg/0.03 mg oral contraceptive kit blister pack labeled for a 28-day cycle. The pack includes rows of circular tablets with instructions indicating white tablets for weeks 1-3 and light green colored tablets for week 4. The dosage form is oral tablets, and the labeler is Teva Pharmaceuticals, Inc. The pack includes days of the week for dosing guidance, with storage instructions for controlled room temperature.*

FDA Label Image

3 (Cryselle Image 6)

An instructional illustration for the Cryselle 0.3 mg/0.03 mg oral tablet kit showing a hand peeling a day-of-week label to place on the tablet pack. The pack is a 28-day supply with a grid layout of four rows labeled as weeks and columns for days, guiding correct daily usage.*

FDA Label Image

1 (Cryselle Image 7)

Cryselle 0.3 mg/0.03 mg oral kit carton label for norgestrel and ethinyl estradiol tablets, USP. The packaging indicates 6 blister card dispensers with 28 tablets each, labeled Rx only. The labeler is Teva Pharmaceuticals, Inc. The NDC code 0480-3493-16 is printed multiple times on the carton label. The packaging includes dosage and usage instructions and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.